| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |